Fig. 4From: Identification of cryptolepine metabolites in rat and human hepatocytes and metabolism and pharmacokinetics of cryptolepine in Sprague Dawley ratsPlasma concentration-time profiles of cryptolepine after single intravenous (1 mg/kg) administrations to Sprague Dawley rats. The lower dotted line indicates the LLOQ (2.2 nM) of LC–MS/MS method for quantifying cryptolepine in rat plasmaBack to article page